| Aspen Pharma Schweiz GmbH - Emla, wirkstoffhaltiges Pflaster | | 52980 | | 01 | | Emla | | wirkstoffhaltiges Pflaster | | N01BB20 | | Combinations | | 14.11.1995 | | |
| | Composition | | lidocainum 25 mg, prilocainum 25 mg, macrogol 54 glyceroli hydroxystearas 19 mg, carbomerum 974P, natrii hydroxidum, aqua purificata ad emulsionem pro 1 g, Trägermaterial: cellulosum, lanugo gossypii absorbens, polyamidum, aluminium metallicum, polyethylenum, acrylic adhesive, ad praeparationem pro 10 cm². | | Packungsbestandteile | | wirkstoffhaltiges Pflaster | | | | | | | | Active Agent | Dose |
|---|
| Lidocaine | 25 mg/g | | Prilocaine | 25 mg/g |
| | BAG: Active Agent | Dose |
|---|
| Lidocaine | 25 mg | | Prilocaine | 25 mg |
| | | | Inactive agents | Dose |
|---|
| Aqua Purificata | | | Carbomerum 974P | | | Lyceroli Hydroxystearas | 19 mg/g | | Macrogol | 54 g | | Sodium Hydroxide | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 2 | | | B | | Yes | | 002 | 20 | | | B | | Yes |
|
|
